SAIC Stock Analysis: Science Applications | NASDAQ
Information Technology Services | NASDAQ, USA | Market Cap: 5.292m USD | 12M Return: 22.3% | US8086251076 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 52.7M
EPS Trend: 91.0%
Qual. Beats: 5
Rev. Trend: -39.6%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Science Applications International Corporation (SAIC) is a U.S.-based provider of technical, engineering, and mission and enterprise information technology services, primarily to federal government customers. Founded in 1969 and headquartered in Reston, Virginia, the company operates through two segments-Defense and Intelligence, and Civilian-serving a broad range of military branches, intelligence agencies, and federal civilian departments, as well as state and local governments.
The company offers a deep portfolio spanning IT modernization, digital engineering, artificial intelligence, mission systems support, training and simulation, ground vehicle support, and quantum technologies. Its mission IT capabilities include CJADC2 (Combined Joint All-Domain Command and Control), data and AI, and digital transformation, while its enterprise IT offerings cover cloud, cybersecurity, service management, and digital workplace solutions. As a government-focused IT services contractor, SAIC operates in a sector characterized by long-term federal contracts, high switching costs, and steady demand driven by defense modernization and cybersecurity priorities.
Formerly known as SAIC Gemini, Inc., the company adopted its current name in September 2013, the same year it became publicly traded on NASDAQ. Its revenue base is heavily concentrated with U.S. federal agencies, making contract awards and government budget cycles key drivers of its business model.
- Defense segment revenue grows on multi-year government IT contracts
- Civilian agency budget shifts pressure federal services margins
- AI and CJADC2 modernization awards drive backlog expansion
| Net Income: 380.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 2.94 > 1.0 |
| NWC/Revenue: 2.93% < 20% (prev -3.26%; Δ 6.19% < -1%) |
| CFO/TA 0.12 > 3% & CFO 660.0m > Net Income 380.0m |
| Net Debt (2.80b) to EBITDA (749.0m): 3.74 < 3 |
| Current Ratio: 1.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.8m) vs 12m ago -8.55% < -2% |
| Gross Margin: 12.65% > 18% (prev 11.49%; Δ 1.16% > 0.5%) |
| Asset Turnover: 139.3% > 50% (prev 143.4%; Δ -4.09% > 0%) |
| Interest Coverage Ratio: 4.39 > 6 (EBIT TTM 592.0m / Interest Expense TTM 135.0m) |
| A: 0.04 (Total Current Assets 1.28b - Total Current Liabilities 1.06b) / Total Assets 5.42b |
| B: 0.26 (Retained Earnings 1.43b / Total Assets 5.42b) |
| C: 0.11 (EBIT TTM 592.0m / Avg Total Assets 5.31b) |
| D: 0.36 (Book Value of Equity 1.44b / Total Liabilities 3.99b) |
| Altman-Z'' = 2.25 = BBB |
| DSRI: 1.06 (Receivables 996.0m/951.0m, Revenue 7.40b/7.46b) |
| GMI: 0.91 (GM 11.49% / 12.65%) |
| AQI: 0.98 (AQ_t 0.70 / AQ_t-1 0.72) |
| SGI: 0.99 (Revenue 7.40b / 7.46b) |
| TATA: -0.05 (NI 380.0m - CFO 660.0m) / TA 5.42b) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of October 08, 2026, the stock is trading at USD 122.08 with a total of 399,661 shares traded. Over the past week, the price has changed by -4.30%, over one month by -4.29%, over three months by +7.75% and over the past year by +22.33%.
Current recommended Stop Loss: 117.60 (which is 3.7% or 1.2 ATR below the current price).
Science Applications has received a consensus analysts rating of 3.18. Therefore, it is recommended to hold SAIC.
- StrongBuy: 2
- Buy: 0
- Hold: 8
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 133.7 | 9.5% |
P/E Trailing = 14.7203
P/E Forward = 10.6496
P/S = 0.7149
P/B = 3.8793
P/EG = 3.67
Revenue TTM = 7.40b USD
EBIT TTM = 592.0m USD
EBITDA TTM = 749.0m USD
Long Term Debt = 2.45b USD (from longTermDebt, last quarter)
Short Term Debt = 33.0m USD (from shortTermDebt, last quarter)
Debt = 2.92b USD (from shortLongTermDebtTotal, last quarter) + Leases 220.0m
Net Debt = 2.80b USD (calculated: Debt 2.92b - CCE 126.0m)
Enterprise Value = 8.09b USD (5.29b + Debt 2.92b - CCE 126.0m)
Interest Coverage Ratio = 4.39 (Ebit TTM 592.0m / Interest Expense TTM 135.0m)
EV/FCF = 13.07x (Enterprise Value 8.09b / FCF TTM 619.0m)
FCF Yield = 7.65% (FCF TTM 619.0m / Enterprise Value 8.09b)
FCF Margin = 8.36% (FCF TTM 619.0m / Revenue TTM 7.40b)
Net Margin = 5.13% (Net Income TTM 380.0m / Revenue TTM 7.40b)
Gross Margin = 12.65% ((Revenue TTM 7.40b - Cost of Revenue TTM 6.47b) / Revenue TTM)
Gross Margin QoQ = 12.71% (prev 13.06%)
Tobins Q-Ratio = 1.49 (Enterprise Value 8.09b / Total Assets 5.42b)
Interest Expense / Debt = 4.62% (Interest Expense 135.0m / Debt 2.92b)
Taxrate = 16.85% (77.0m / 457.0m)
NOPAT = 492.3m (EBIT 592.0m * (1 - 16.85%))
Current Ratio = 1.20 (Total Current Assets 1.28b / Total Current Liabilities 1.06b)
Debt / Equity = 2.04 (Debt 2.92b / totalStockholderEquity, last quarter 1.44b)
Debt / EBITDA = 3.74 (Net Debt 2.80b / EBITDA 749.0m)
Debt / FCF = 4.52 (Net Debt 2.80b / FCF TTM 619.0m)
Total Stockholder Equity = 1.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.15% (Net Income 380.0m / Total Assets 5.42b)
RoE = 25.89% (Net Income TTM 380.0m / Total Stockholder Equity 1.47b)
RoCE = 15.10% (EBIT 592.0m / Capital Employed (Equity 1.47b + L.T.Debt 2.45b))
RoIC = 11.53% (NOPAT 492.3m / Invested Capital 4.27b)
WACC = 5.32% (E(5.29b)/V(8.22b) * Re(6.14%) + D(2.92b)/V(8.22b) * Rd(4.62%) * (1-Tc(0.17)))
Discount Rate = 6.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.32 | Cagr: -8.37%
[DCF] Terminal Value 77.97% ; FCFF base≈547.8m ; Y1≈628.0m ; Y5≈924.2m
[DCF] Fair Price = 265.1 (EV 13.9b - Net Debt 2.80b = Equity 11.1b / Shares 41.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 91.04 | EPS CAGR: 18.26% | SUE: 1.60 | # QB: 5
Revenue Correlation: -39.60 | Revenue CAGR: -0.71% | SUE: 2.22 | # QB: 2
EPS current Quarter (2026-10-31): EPS=2.34 | Chg30d=-1.64% | Revisions=-30% | Analysts=9
EPS current Year (2027-01-31): EPS=10.81 | Chg30d=+6.24% | Revisions=+75% | GrowthEPS=+0.6% | GrowthRev=+0.5%
EPS next Year (2028-01-31): EPS=11.48 | Chg30d=+4.39% | Revisions=+36% | GrowthEPS=+6.2% | GrowthRev=+1.4%
[Analyst] Revisions Ratio: +37% (up=17, down=7)